A clinico-genomic analysis of soft tissue sarcoma patients reveals CDKN2A deletion as a biomarker for poor prognosis

BACKGROUND: Sarcomas are a rare, heterogeneous group of tumors with variable tendencies for aggressive behavior. Molecular markers for prognosis are needed to risk stratify patients and identify those who might benefit from more intensive therapeutic strategies. PATIENTS AND METHODS: We analyzed som...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Clin Sarcoma Res
Main Authors: Bui, Nam Q., Przybyl, Joanna, Trabucco, Sally E., Frampton, Garrett, Hastie, Trevor, van de Rijn, Matt, Ganjoo, Kristen N.
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2019
Assuntos:
Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6739971/
https://ncbi.nlm.nih.gov/pubmed/31528332
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13569-019-0122-5
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados